Sm - 0.2mg

Sm - 0.2mg

Regular price
$717.13
Regular price
Sale price
$717.13
Unit price
per 
Availability
Sold out

Smith antigens
nRNP D subunit

Uniprot ID:  Q3ZC10 Q3SZF8 F1MZ00
mRNA RefSeq:  NM_001035065 NM_001034476
Protein RefSeq:  NP_001030237 NP_001029648

Size: 0.2mg
Source: Calf Thymus
Catalogue Number: ATS02-02

Product Information

Anti-Smith (Sm) antibodies are found in the sera of approximately 25% of all patients with systemic lupus erythematosus (SLE) and their presence is considered to be a very specific marker of this disease. Autoantibodies to Sm are also known to often occur in combination with autoantibodies to other antigens, including DNA, histone, RNP, SSA(Ro) and SSB(La).

The term "Sm antigen" is now known to be synonymous with at least nine different polypeptides. These proteins are also known as the common or core proteins of snRNP particles. snRNPs are a group of nuclear particles comprised of several polypeptides associated with a small nuclear RNA molecule.  The most abundant snRNPs are involved in pre-mRNA-splicing. Since they bind to proteins common to different snRNP particles (B, D, E, F and G subunits), autoantibodies directed against Sm are able to precipitate a wide range of snRNAs.

While the major Sm autoantigen is believed to be represented by the D polypeptide, the B and D proteins are known to share at least one epitope based on monoclonal antibodies with multiple specificities. Sequence comparison has shown that all the known Sm proteins share two evolutionarily conserved structural sequence motifs, a possible explanation for their immunological cross-reactivity.

Sm D polypeptide subtypes represent the most abundant components of AROTEC's Sm antigen. It has been shown elsewhere that the D polypeptide exhibits a much higher specificity for Sm autoantibodies than the B polypeptide does. Other Sm subunits (E,F,G) are detectable. Human Sm D1, D2 and D3 are identical to the bovine sequences indicating that the antigens are highly conserved across mammalian species.

PDF-logo-dl Sm datasheet

Clinical Indications

Systemic Lupus Erythematosus

MSDS

PDF-logo-dl  Material Safety Data Sheet

References

Tan, E.M. & Kunkel, H.G. (1966) J. Immunol. 96, 464

Notman, D.D. et al. (1975) Ann. Intern. Med. 83, 464

Tan, E.M. et al. (1988) Clin. Immunol. Pathol. 47, 121

Habets, W.J. et al. (1990) Arthritis Rheum. 33, 834

Hoch, S. (1994) Man. Biol. Markers of Dis. (Kluwer Acad. Publ.)B4:1-29

Lerner, M.R. & Steitz, J.A. (1979) Proc. Natl. Acad. Sci. USA 76, 5495

Reuter, R. et al. (1990) Eur. J. Immunol. 20, 437

Petersson, I. et al. (1984) J. Biol. Chem. 259, 5907

Combe, B. et al. (1989) Clin. Exp. Immunol. 75, 18

Francoeur, A.M. (1989) J. Clin. Immunol. 9, 256

Williams, D.G et al. (1986) Immunology 58, 495

Seraphin, B. (1995) EMBO J. 14, 2089

Hermann, H. et al. (1995) EMBO J. 14, 2076

Lehmeier, T. et al. (1990) Nucleic Acids Res. 18, 6475

Blazek, M. et al, (1992) Z. Rheumatol. 51, 87

Duran, N. et al. (1984) Mol. Immunol. 21, 731

Yasuma, M. et al. (1990) J. Rheumatol. 17, 469

Zhang, W. & Reichlin, M. (1995) Clin. Immunol. Immunopathol. 74, 1995

Lehmeier, T. et al. (1994) Proc. Natl. Acad. Sci. USA 91, 12317

Winteroe, A.K. et al. (1996) Mamm. Genome 7, 509

Rokeach, L.A. et al. (1988) Proc. Natl. Acad. Sci. USA 85, 4832

Strausberg, R.L. et al. (2002) Proc. Natl. Acad. Sci. USA 99, 16899